Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • imsharmanitin
    Postdoc Cancer Bioinformatics
    • Dec 2014
    • 17

    is this a technical replicate or biological replicate

    i know that biological replicate is one taken from different organism/sample while technical replicate is one from same organism/sample.

    However, I am not able to understand that a cell line treated with a drug three times separately to generate RNA-Seq data will be considered as biological replicate or technical replicate or a biological replicate but not in a strict sense. Also, will this be applicable for control sample?

    Thanks in advance
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I think it would be biological replicates and the same goes for control which should be treated with solvent without the drug. I imagine that there will be other treatments such as exposure time and dose as well in such experiments.

    Comment

    • jaspersaris
      Member
      • Nov 2008
      • 6

      #3
      As the variation during cultering is expected (and often is) far more variable then the technical reproducibility the biological replicate would be to repeat the actual incubations i.e. three times (for a triplicate).
      A technical replicate would be having the same RNA sample sequenced two times (i.e. a duplo).
      Often an experiment is repeated three times, getting n=3 for the experiment and statistics. In the experiment an incubation can be in duplo (i.e. two flasks stimulated with the same compound). Each incubation is then sequenced once.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...